VanEck Vectors Net Asset

BBH -- USA Etf  

USD 123.19  1.59  1.31%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Net Asset Analysis

Net Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
VanEck Vectors 
Net Asset 
Current Market Value 
Current Liabilities 
418.63 M

About Net Asset

Net Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
Compare to competition
Based on recorded statements VanEck Vectors Biotech ETF has Net Asset of 418.63 M. This is 30.27% higher than that of the Van Eck family, and 94.15% higher than that of Health category, The Net Asset for all etfs is 52.9% higher than the company.

Peer Comparison

VanEck Vectors Net Asset Comparison
  Net Asset 
      VanEck Vectors Comparables 
VanEck Vectors is currently under evaluation in net asset as compared to similar ETFs.

Did you try this?

Run Portfolio Suggestion Now

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Portfolio Suggestion

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Asset Allocation

Fund Instrument Allocation for VanEck Vectors
The fund invests 100.0% of asset under management in tradable equity instruments, with the rest of investments concentrated in .
      Instrument Type 

Fundamental Indicators

Current VanEck Vectors financial ratios